Chernysh Sergey, Gordya Natalia, Tulin Dmitry, Yakovlev Andrey
Laboratory of Insect Biopharmacology and Immunology, Faculty of Biology, St. Petersburg State University, St. Petersburg, Russia.
Infect Drug Resist. 2018 Apr 9;11:501-514. doi: 10.2147/IDR.S157847. eCollection 2018.
The aim of this study is to improve the anti-biofilm activity of antibiotics. We hypothesized that the antimicrobial peptide (AMP) complex of the host's immune system can be used for this purpose and examined the assumption on model biofilms.
FLIP7, the AMP complex of the blowfly containing a combination of defensins, cecropins, diptericins and proline-rich peptides was isolated from the hemolymph of bacteria-challenged maggots. The complex interaction with antibiotics of various classes was studied in biofilm and planktonic cultures of , , , and by the checkerboard method using trimethyl tetrazolium chloride cell viability and crystal violet biofilm eradication assays supplemented with microscopic analysis.
We found that FLIP7 demonstrated: high synergy (fractional inhibitory concentration index <0.25) with meropenem, amikacin, kanamycin, ampicillin, vancomycin and cefotaxime; synergy with clindamycin, erythromycin and chloramphenicol; additive interaction with oxacillin, tetracycline, ciprofloxacin and gentamicin; and no interaction with polymyxin B. The interaction in planktonic cell models was significantly weaker than in biofilms of the same strains. The analysis of the dose-effect curves pointed to persister cells as a likely target of FLIP7 synergistic effect. The biofilm eradication assay showed that the effect also caused total destruction of and biofilm materials. The effect allowed reducing the effective anti-biofilm concentration of the antibiotic to a level well below the one clinically achievable (2-3 orders of magnitude in the case of meropenem, ampicillin, cefotaxime and oxacillin).
FLIP7 is a highly efficient host antimicrobial system helping antibiotics to overcome biofilm barriers through persisters' sensitization and biofilm material destruction. It is promising for the treatment of biofilm infections as an adjuvant of various small-molecule antibiotics.
本研究旨在提高抗生素的抗生物膜活性。我们假设宿主免疫系统的抗菌肽(AMP)复合物可用于此目的,并在模型生物膜上检验了这一假设。
从经细菌感染的蛆的血淋巴中分离出FLIP7,这是一种家蝇的AMP复合物,包含防御素、天蚕素、双翅肽和富含脯氨酸的肽的组合。通过棋盘法,利用氯化三甲基四氮唑细胞活力测定和结晶紫生物膜根除试验并辅以显微镜分析,研究了该复合物与各类抗生素在金黄色葡萄球菌、大肠杆菌、铜绿假单胞菌、鲍曼不动杆菌和白色念珠菌的生物膜和浮游培养物中的相互作用。
我们发现FLIP7表现出:与美罗培南、阿米卡星、卡那霉素、氨苄西林、万古霉素和头孢噻肟具有高度协同作用(分数抑制浓度指数<0.25);与克林霉素、红霉素和氯霉素具有协同作用;与苯唑西林、四环素、环丙沙星和庆大霉素具有相加相互作用;与多粘菌素B无相互作用。在浮游细胞模型中的相互作用明显弱于相同菌株的生物膜中的相互作用。剂量效应曲线分析表明,持续存在细胞可能是FLIP7协同效应的靶点。生物膜根除试验表明,该效应还导致金黄色葡萄球菌和白色念珠菌生物膜物质的完全破坏。该效应可将抗生素的有效抗生物膜浓度降低至远低于临床可达到的水平(对于美罗培南、氨苄西林、头孢噻肟和苯唑西林,降低2 - 3个数量级)。
FLIP7是一种高效的宿主抗菌系统,通过使持续存在细胞敏感化和破坏生物膜物质来帮助抗生素克服生物膜屏障。作为各种小分子抗生素的佐剂,它在治疗生物膜感染方面具有前景。